Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Christine Mathieu

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial)Céline Bourgier, Charlotte Pichenot, Rodolfe Verstraet, et al.
Radiation Oncology (London, England)|August 24, 2012
Higher toxicity with 42 Gy in 10 fractions as a total dose for 3D-conformal accelerated partial breast irradiation: results from a dose escalation phase II trialCeline Bourgier, Catalina Acevedo-Henao, Ariane Dunant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2010
Trastuzumab treatment in t1ab, node-negative, human epidermal growth factor receptor 2-overexpressing breast carcinomasManuel Jorge Rodrigues, Johanna Wassermann, Laurence Albiges, et al.
Clinical Breast Cancer|March 20, 2010
Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imagingElisabeth Chéreau, Catherine Uzan, Corinne Balleyguier, et al.
Molecular Oncology|August 25, 2016
Concordance between HER-2 status determined by qPCR in Fine Needle Aspiration Cytology (FNAC) samples compared with IHC and FISH in Core Needle Biopsy (CNB) or surgical specimens in breast cancer patientsClaudia Rodriguez, Voichita Suciu, Audrey Poterie, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2006
High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS studyMagali Lacroix-Triki, Simone Mathoulin-Pelissier, Jean-Pierre Ghnassia, et al.
Journal of Medical Imaging (Bellingham, Wash.)|June 5, 2023
Automatic diagnosis and classification of breast surgical samples with dynamic full-field OCT and machine learningJules Scholler, Diana Mandache, Marie Christine Mathieu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Malignant breast tumors after radiotherapy for a first cancer during childhoodCatherine Guibout, Elisabeth Adjadj, Carole Rubino, et al.
BJS Open|May 13, 2023
Breast carcinoma detection in ex vivo fresh human breast surgical specimens using a fast slide-free confocal microscopy scanner: HIBISCUSS projectAngelica Conversano, Muriel Abbaci, Paul van Diest, et al.
European Radiology|January 7, 2018
Preclinical ex vivo evaluation of the diagnostic performance of a new device for in situ label-free fluorescence spectral analysis of breast massesMarie-Christine Mathieu, Alexis Toullec, Charlotte Benoit, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial)Céline Bourgier, Charlotte Pichenot, Rodolfe Verstraet, et al.
Radiation Oncology (London, England)|August 24, 2012
Higher toxicity with 42 Gy in 10 fractions as a total dose for 3D-conformal accelerated partial breast irradiation: results from a dose escalation phase II trialCeline Bourgier, Catalina Acevedo-Henao, Ariane Dunant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2010
Trastuzumab treatment in t1ab, node-negative, human epidermal growth factor receptor 2-overexpressing breast carcinomasManuel Jorge Rodrigues, Johanna Wassermann, Laurence Albiges, et al.
Clinical Breast Cancer|March 20, 2010
Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imagingElisabeth Chéreau, Catherine Uzan, Corinne Balleyguier, et al.
Molecular Oncology|August 25, 2016
Concordance between HER-2 status determined by qPCR in Fine Needle Aspiration Cytology (FNAC) samples compared with IHC and FISH in Core Needle Biopsy (CNB) or surgical specimens in breast cancer patientsClaudia Rodriguez, Voichita Suciu, Audrey Poterie, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2006
High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS studyMagali Lacroix-Triki, Simone Mathoulin-Pelissier, Jean-Pierre Ghnassia, et al.
Journal of Medical Imaging (Bellingham, Wash.)|June 5, 2023
Automatic diagnosis and classification of breast surgical samples with dynamic full-field OCT and machine learningJules Scholler, Diana Mandache, Marie Christine Mathieu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Malignant breast tumors after radiotherapy for a first cancer during childhoodCatherine Guibout, Elisabeth Adjadj, Carole Rubino, et al.
BJS Open|May 13, 2023
Breast carcinoma detection in ex vivo fresh human breast surgical specimens using a fast slide-free confocal microscopy scanner: HIBISCUSS projectAngelica Conversano, Muriel Abbaci, Paul van Diest, et al.
European Radiology|January 7, 2018
Preclinical ex vivo evaluation of the diagnostic performance of a new device for in situ label-free fluorescence spectral analysis of breast massesMarie-Christine Mathieu, Alexis Toullec, Charlotte Benoit, et al.
Pageof 9